Publicacións en colaboración con investigadores/as de McGill University (9)

2024

  1. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 668-682

2019

  1. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

    Cancer Cell, Vol. 36, Núm. 1, pp. 51-67.e7

  2. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

    Nature Communications, Vol. 10, Núm. 1

2017

  1. Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Cancer Cell, Vol. 31, Núm. 6, pp. 737-754.e6

  2. Pediatric low-grade gliomas: Implications of the biologic era

    Neuro-Oncology, Vol. 19, Núm. 6, pp. 750-761

  3. Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas

    Journal of Clinical Oncology, Vol. 35, Núm. 25, pp. 2934-2941

2016

  1. Phase II weekly vinblastine for chemotherapy-naïve children with progressive low-grade glioma: A Canadian pediatric brain tumor consortium study

    Journal of Clinical Oncology, Vol. 34, Núm. 29, pp. 3537-3543

  2. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

    The Lancet Oncology, Vol. 17, Núm. 4, pp. 484-495

  3. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis

    Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477